el-Safi S H, Peters W, el-Toam B, el-Kadarow A, Evans D A
Institute for Tropical Medicine, Khartoum, Sudan.
Trans R Soc Trop Med Hyg. 1991 Jul-Aug;85(4):457-64. doi: 10.1016/0035-9203(91)90218-n.
In the Omdurman Hospital for Tropical Diseases, Sudan, from 6 October to 1 December 1986, 736 patients with cutaneous leishmaniasis (CL) were studied. The duration of the lesions varied from a few days to 4 months, usually (56%) 1-3 months. Multiple lesions ranging from one to 50 (mean = 4) were present in 80% of cases. Ulcerative lesions were found in 44%, nodulo-ulcerative in 31%, nodular in 31% and others, including infiltrated, fungating and warty lesions, in 5% of patients. The lower limbs were involved in 66%, upper limbs in 50%, face in 6%, back in 4%, chest in 2%, abdomen in 1% and buttocks in 0.1%. Lesions were also found on the ear, scalp, genitalia and mucocutaneous junctions. Lymphatic involvement was present in 11% of the patients, secondary infection in 18%, fever in 17%, pain in 38% and itching in 61%; 3% of the patients were diabetics. Features of diffuse cutaneous leishmaniasis were noted in one patient and three cases presented with an 'id' reaction. A slit-skin smear was positive in 88% of the cases. Using thin-layer starch gel electrophoresis, 23 stocks from man and one from Arvicanthis niloticus were identified by the characterization of 12 enzymes as Leishmania major zymodeme LON-1. Various therapeutic regimens are discussed. Only patients with severe lesions (approximately 15%) were given 3 to 4 weeks' treatment with intravenous Pentostam, to which all except 2 responded satisfactorily with minimal side effects.
1986年10月6日至12月1日期间,在苏丹恩图曼热带病医院,对736例皮肤利什曼病患者进行了研究。皮损持续时间从几天到4个月不等,通常(56%)为1 - 3个月。80%的病例有1至50个(平均4个)多发皮损。44%的患者有溃疡性皮损,31%为结节溃疡性,31%为结节性,5%为其他类型,包括浸润性、蕈样和疣状皮损。下肢受累占66%,上肢占50%,面部占6%,背部占4%,胸部占2%,腹部占1%,臀部占0.1%。耳部、头皮、生殖器和黏膜皮肤交界处也发现有皮损。11%的患者有淋巴管受累,18%有继发感染,17%发热,38%疼痛,61%瘙痒;3%的患者为糖尿病患者。1例患者有弥漫性皮肤利什曼病的特征,3例出现“id”反应。88%的病例皮肤涂片检查呈阳性。采用薄层淀粉凝胶电泳法,通过对12种酶的特征分析,将来自人类的23株菌株和来自尼罗多乳鼠的1株菌株鉴定为硕大利什曼原虫酶带型LON - 1。文中讨论了各种治疗方案。只有病情严重的患者(约15%)接受了3至4周的静脉注射喷他脒治疗,除2例患者外,其余患者均对治疗反应良好,副作用极小。